Abstract:We consider a three-dimensional mathematical model that describes the interaction between the effector cells, tumor cells, and the cytokine (IL-2) of a patient. This is called the Kirschner-Panetta model. Our objective is to explain the tumor oscillations in tumor sizes as well as long-term tumor relapse. We then explore the effects of adoptive cellular immunotherapy on the model and describe under what circumstances the tumor can be eliminated or can remain over time but in a controlled manner. Nonlinear dynamics of immunogenic tumors are given, for example: we prove that the trajectories of the associated system are bounded and defined for all positive time; there are some invariant subsets; there are open subsets of parameters, such that the system in the first octant has at most five equilibrium solutions, one of them is tumor-free and the others are of co-existence. We are able to prove the existence of transcritical and pitchfork bifurcations from the tumor-free equilibrium point. Fixing an equilibrium and introducing a small perturbation, we are able to show the existence of a Hopf periodic orbit, showing a cyclic behavior among the population, with a strong dominance of the parental anomalous growth cell population. The previous information reveals the effects of the parameters. In our study, we observe that our mathematical model exhibits a very rich dynamic behaviour and the parameter μ̃ (death rate of the effector cells) and p̃1 (production rate of the effector cell stimulated by the cytokine IL-2) plays an important role. More precisely, in our approach the inequality μ̃2>p̃1 is very important, that is, the death rate of the effector cells is greater than the production rate of the effector cell stimulated by the cytokine IL-2. Finally, medical implications and a set of numerical simulations supporting the mathematical results are also presented.

Mathematical modeling of anti-tumor virus therapy: Regimes with complete recovery within the framework of deterministic models

A mathematical model of tumor-immune interactions incorporated with danger model

Mathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics

Mathematical modeling and dynamic analysis of anti-tumor immune response

Modeling and analysis of nonlinear tumor‐immune interaction under chemotherapy and radiotherapy

Mathematical Modeling and Analysis of Tumor Chemotherapy

Mathematical analysis of an HIV model with latent reservoir, delayed CTL immune response and immune impairment

Different Strategies for Cancer Treatment: Mathematical Modeling

A general framework for modeling tumor-immune system competition and immunotherapy: mathematical analysis and biomedical inferences

A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach

Oncolytic virotherapy for tumours following a Gompertz growth law

Qualitative and Computational Analysis of a Mathematical Model for Tumor-Immune Interactions

Mathematical modeling of combined therapies for treating tumor drug resistance

Modeling oncolytic virus therapy with distributed delay and non-local diffusion

The role of viral infectivity in oncolytic virotherapy outcomes: A mathematical study

Dynamics aspects and bifurcations of a tumor-immune system interaction under stationary immunotherapy

Mathematical Modeling and Analysis of the Dynamics of RNA Viruses in Presence of Immunity and Treatment: A Case Study of SARS-CoV-2

Maximization of viability time in a mathematical model of cancer therapy

Mathematical model of immune response to hepatitis B

The local and global dynamics of a cancer tumor growth and chemotherapy treatment model

Dynamic behaviors of a stochastic virus infection model with Beddington–DeAngelis incidence function, eclipse-stage and Ornstein–Uhlenbeck process